HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.

Abstract
The emergence of drug resistance is a major limitation of current antimalarials. The discovery of new druggable targets and pathways including those that are critical for multiple life cycle stages of the malaria parasite is a major goal for developing next-generation antimalarial drugs. Using an integrated chemogenomics approach that combined drug resistance selection, whole-genome sequencing, and an orthogonal yeast model, we demonstrate that the cytoplasmic prolyl-tRNA (transfer RNA) synthetase (PfcPRS) of the malaria parasite Plasmodium falciparum is a biochemical and functional target of febrifugine and its synthetic derivative halofuginone. Febrifugine is the active principle of a traditional Chinese herbal remedy for malaria. We show that treatment with febrifugine derivatives activated the amino acid starvation response in both P. falciparum and a transgenic yeast strain expressing PfcPRS. We further demonstrate in the Plasmodium berghei mouse model of malaria that halofuginol, a new halofuginone analog that we developed, is active against both liver and asexual blood stages of the malaria parasite. Halofuginol, unlike halofuginone and febrifugine, is well tolerated at efficacious doses and represents a promising lead for the development of dual-stage next-generation antimalarials.
AuthorsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, Guillermina Estiu, Kevin Galinsky, Vanessa Zuzarte-Luis, Emily R Derbyshire, Ulf Ribacke, Amanda K Lukens, Sofia A Santos, Vishal Patel, Clary B Clish, William J Sullivan Jr, Huihao Zhou, Selina E Bopp, Paul Schimmel, Susan Lindquist, Jon Clardy, Maria M Mota, Tracy L Keller, Malcolm Whitman, Olaf Wiest, Dyann F Wirth, Ralph Mazitschek
JournalScience translational medicine (Sci Transl Med) Vol. 7 Issue 288 Pg. 288ra77 (May 20 2015) ISSN: 1946-6242 [Electronic] United States
PMID25995223 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2015, American Association for the Advancement of Science.
Chemical References
  • Antimalarials
  • Enzyme Inhibitors
  • Piperidines
  • Protozoan Proteins
  • Quinazolines
  • Quinazolinones
  • febrifugine
  • Amino Acyl-tRNA Synthetases
  • prolyl T RNA synthetase
  • halofuginone
Topics
  • Amino Acyl-tRNA Synthetases (antagonists & inhibitors, metabolism)
  • Animals
  • Antimalarials (chemistry, pharmacology, toxicity)
  • Computer-Aided Design
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Design
  • Drug Resistance
  • Enzyme Inhibitors (chemistry, pharmacology, toxicity)
  • Erythrocytes (parasitology)
  • Liver (parasitology)
  • Malaria, Falciparum (blood, drug therapy, parasitology)
  • Mice
  • Models, Molecular
  • Molecular Structure
  • Molecular Targeted Therapy
  • Piperidines (chemistry, pharmacology, toxicity)
  • Plasmodium falciparum (drug effects, enzymology)
  • Protozoan Proteins (antagonists & inhibitors, metabolism)
  • Quinazolines (chemistry, pharmacology, toxicity)
  • Quinazolinones (chemistry, pharmacology, toxicity)
  • Structure-Activity Relationship
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: